Expression of the ether-a-go-go (ERG) potassium channel in smooth muscle of the equine gastrointestinal tract and influence on activity of jejunal smooth muscle

American Journal of Veterinary Research

Volumn 64, Issue 3, 2003, Pages 267-272

  Lillich, James D ^a   Rakestraw, Peter C ^b   Roussel, Allen J ^b   Finley, Melissa R ^a,c   Ganta, Suhasini ^a   Freeman, Lisa C ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; 1' (6 CYANO 1,2,3,4 TETRAHYDRO 2 NAPHTHYL) 3,4 DIHYDRO 6 METHANESULFONAMIDOSPIRO[2H 1 BENZOPYRAN 2,4' PIPERIDIN] 4 OL; CISAPRIDE; CLOFILIUM; DOMPERIDONE; ERYTHROMYCIN; METOCLOPRAMIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROKINETIC AGENT; SEROTONIN AGONIST; ERG1 POTASSIUM CHANNEL; GASTROINTESTINAL AGENT; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CECUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESEARCH; DRUG RESPONSE; DRUG SELECTIVITY; DRUG TARGETING; DUODENUM; HORSE; ILEUM; ILEUS; IMMUNOBLOTTING; IN VITRO STUDY; INTESTINE MOTILITY; INTESTINE MUSCLE; ISOMETRICS; JEJUNUM; LARGE INTESTINE; NONHUMAN; POSTOPERATIVE PERIOD; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SMALL INTESTINE; SMOOTH MUSCLE; SMOOTH MUSCLE CONTRACTION; STRESS; ANIMAL; BLOOD; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; TIME; WESTERN BLOTTING;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

ANIMALS; BLOTTING, WESTERN; CISAPRIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTROINTESTINAL AGENTS; GENE EXPRESSION; HORSES; JEJUNUM; MUSCLE CONTRACTION; MUSCLE, SMOOTH; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; TIME FACTORS;

EID: 0038282829     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2003.64.267     Document Type: Article

References (46)

1. Blikslager AT, Bowman KF, Levine JF, et al. Evaluation of factors associated with postoperative ileus in horses: 31 cases (1990-1992). J Am Vet Med Assoc 1994;205:1748-1752.
2. Roussel AJ Jr, Cohen ND, Hooper RN, et al. Risk factors associated with development of postoperative ileus in horses. J Am Vet Med Assoc 2001;219:72-78.
3. Dart AJ, Hodgson DR. Role of prokinetic drugs for treatment of postoperative ileus in the horse. Aust Vet J 1998;76:25-31.
4. DeGeest J, Vlaminick K, Myuelle E, et al. A clinical study of cisapride in horses after colic surgery. Equine Vet Educ 1991;3:138-142.
5. Gerring EL, King JN. Cisapride in the prophylaxis of equine post operative ileus. Equine Vet J Suppl 1989;7:52-55.
6. Gerring EL, King JN, Edwards GB, et al. A multicentre trial of cisapride in the prophylaxis of equine postoperative ileus. Equine Vet Educ 1991;3:143-145.
7. King JN, Gerring EL. Actions of the novel gastrointestinal prokinetic agent cisapride on equine bowel motility. J Vet Pharmacol Ther 1988;11:314-321.
8. Steiner A, Roussel AJ. Drugs coordinating and restoring gastrointestinal motility and their effect on selected hypodynamic gastrointestinal disorders in horses and cattle. Zentralbl Veterinarmed A 1995;42:613-631.
9. Valk N, Doherty TJ, Blackford JT, et al. Effect of cisapride on gastric emptying in horses following endotoxin treatment. Equine Vet J 1998;30:344-348.
10. van der Velden MA, Klein WR. The effects of cisapride on the restoration of gut motility after surgery of the small intestine in horses; a clinical trial. Vet Q 1993;15:175-179.
11. Nieto JE, Rakestraw PC, Snyder JR, et al. In vitro effects of erythromycin, lidocaine, and metoclopramide on smooth muscle from the pyloric antrum, proximal portion of the duodenum, and middle portion of the jejunum of horses. Am J Vet Res 2000;61:413-419.
12. Ringger NC, Lester GD, Neuwirth L, et al. Effect of bethanechol or erythromycin on gastric emptying in horses. Am J Vet Res 1996;57:1771-1775.
13. Roussel AJ, Hooper RN, Cohen ND, et al. Prokinetic effects of erythromycin on the ileum, cecum, and pelvic flexure of horses during the postoperative period. Am J Vet Res 2000;61:420-424.
14. Nieto JE, Snyder JR, Kollias-Baker C, et al. In vitro effects of 5-hydroxytryptamine and cisapride on the circular smooth muscle of the jejunum of horses. Am J Vet Res 2000;61:1561-1565.
15. Sasaki N, Yoshihara T. The effect of orally administered cisapride on intestinal motility in conscious horses. J Vet Med Sci 2000; 62:211-213.
16. Wysowski DK, Corken A, Gallo-Torres H, et al. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatoryactions. Am J Gastroenterol 2001;96:1698-1703.
17. Mohammad S, Zhou Z, Gong Q, et al. Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride. Am J Physiol 1997;273:H2534-H2538.
18. Rampe D, Roy ML, Dennis A, et al. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG. FEBS Lett 1997;417:28-32.
19. Finley MR, Li Y, Hua F, et al. Expression and co-association of ERG1, KCNQ1 and KCNE1 potassium channel proteins in horse heart. Am J Physiol Heart Circ Physiol 2002;283:H126-H138.
20. Fujii K, Okajima M, Kawahori K. Effect of cisapride on the cholinergic control mechanisms of gastrointestinal motility in dogs. Nippon Heikatsukin Gakkai Zasshi 1988;24:1-12.
21. Schuurkes JA, Van Nueten JM, Van Daele PG, et al. Motor-stimulating properties of cisapride on isolated gastrointestinal preparations of the guinea pig. J Pharmacol Exp Ther 1985;234:775-783.
22. Syed M, Tokuno H, Tomita T. Effects of cisapride on isolated guinea pig colon. Jpn J Pharmacol 1989;51:47-56.
23. Washabau RJ, Hall JA. Cisapride. J Am Vet Med Assoc 1995; 207:1285-1288.
24. Washabau RJ, Sammarco J. Effects of cisapride on feline colonic smooth muscle function. Am J Vet Res 1996;57:541-546.
25. Akbarali HI, Thatte H, He XD, et al. Role of HERG-like K(+) currents in opossum esophageal circular smooth muscle. Am J Physiol 1999;277:C1284-C1290.
26. Ohya S, Asakura K, Muraki K, et al. Molecular and functional characterization of ERG, KCNQ, and KCNE subtypes in rat stomach smooth muscle. Am J Physiol Gastrointest Liver Physiol 2002; 282:G277-G287.
27. Drolet B, Rousseau G, Daleau P, et al. Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation 2000;102:1883-1885.
28. Berube J, Caouette D, Daleau P. Hydrogen peroxide modifies the kinetics of HERG channel expressed in a mammalian cell line. J Pharmacol Exp Ther 2001;297:96-102.
29. Taglialatela M, Castaldo P, Iossa S, et al. Regulation of the human ether-a-gogo related gene (HERG) K+ channels by reactive oxygen species. Proc Natl Acad Sci U S A 1997;94:11698-11703.
30. Pond AL, Scheve BK, Benedict AT, et al. Expression of distinct ERG proteins in rat, mouse, and human heart. Relation to functional I(Kr) channels. J Biol Chem 2000;275:5997-6006.
31. Zhou Z, Gong Q, Ye B, et al. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys J 1998;74:230-241.
32. Cook G, Papich MG, Roberts MC, et al. Pharmacokinetics of cisapride in horses after intravenous and rectal administration. Am J Vet Res 1997;58:1427-1430.
33. Sanguinetti MC, Jurkiewicz NK. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 1990;96:195-215.
34. Lynch JJ Jr, Wallace AA, Stupienski RF III, et al. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499]. J Pharmacol Exp Ther 1994;269:541-554.
35. Arena JP, Kass RS. Block of heart potassium channels by clofilium and its tertiary analogs: relationship between drug structure and type of channel blocked. Mol Pharmacol 1988;34:60-66.
36. Suessbrich H, Schonherr R, Heinemann SH, et al. Specific block of cloned Herg channels by clofilium and its tertiary analog LY97241. FEBS Lett 1997;414:435-438.
37. Gong Q, Anderson CL, January CT, et al. Role of glycosylation in cell surface expression and stability of HERG potassium channels. Am J Physiol Heart Circ Physiol 2002;283:H77-H84.
38. Petrecca K, Atanasiu R, Akhavan A, et al. N-linked glycosylation sites determine HERG channel surface membrane expression. J Physiol 1999;515:41-48.
39. Hasler AH, Washabau RJ. Cisapride stimulates contraction of idiopathic megacolonic smooth muscle in cats. J Vet Intern Med 1997;11:313-318.
40. Le Grand B, Marty A, Colpaert FC, et al. Ketanserin inhibits the transient outward current in rabbit ventricular myocytes. J Cardiovasc Pharmacol 1995;25:341-344.
41. Le Grand B, Talmant JM, Rieu JP, et al. Investigation of the mechanism by which ketanserin prolongs the duration of the cardiac action potential. J Cardiovasc Pharmacol 1995;26:803-809.
42. Zhang ZH, Boutjdir M, el Sherif N. Ketanserin inhibits depolarization-activated outward potassium current in rat ventricular myocytes. Circ Res 1994;75:711-721.
43. Steel CM, Bolton JR, Preechagoon Y, et al. Pharmacokinetics of cisapride in the horse. J Vet Pharmacol Ther 1998;21:433-436.
44. Drolet B, Khalifa M, Daleau P, et al. Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval. Circulation 1998;97:204-210.
45. Dumotier BM, Bastide M, Adamantidis MM. "Use-dependent" effects of cisapride on postrest action potentials in rabbit ventricular myocardium. Eur J Pharmacol 2001;422:137-148.
46. Potet F, Bouyssou T, Escande D, et al. Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-a-gogo K(+) channel. J Pharmacol Exp Ther 2001;299:1007-1012.